<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Treatment of tinnitus
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Treatment of tinnitus
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Treatment of tinnitus
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth A Dinces, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel G Deschler, MD, FACS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jane Givens, MD, MSCE
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 25, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tinnitus is a perception of sound in proximity to the head in the absence of an external source. The sound may be a buzzing, ringing, or hissing, although it can also sound like other noises.
        </p>
        <p>
         Tinnitus is most commonly associated with hearing loss, though it may be a presenting symptom of vascular or neurologic abnormalities. Once a serious underlying medical condition has been ruled out, treatment should be directed at the symptom itself, which severely interferes with the quality of life in approximately 10 percent of patients with tinnitus [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         This topic will review the treatment of tinnitus. The epidemiology, pathogenesis, and diagnosis of tinnitus are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6855.html" rel="external">
          "Etiology and diagnosis of tinnitus"
         </a>
         .)
        </p>
        <p>
         Treatment for tinnitus includes correcting identified causes and comorbidities as well as directly addressing the effects of tinnitus on quality of life. For many patients, tinnitus is a chronic condition; goals of treatment are to lessen its impact and any associated disability, rather than to achieve absolute cure. Several treatment modalities have been studied, including behavioral treatments and medications, but the benefit for most of these interventions has not been conclusively demonstrated in randomized trials [
         <a href="#rid2">
          2-4
         </a>
         ]. High-quality treatment trials are lacking [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1534544446">
         <span class="h1">
          ADDRESSING PATIENT CONCERNS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients may be concerned that tinnitus is a symptom of something worrisome. If, after an appropriate evaluation, the cause is determined not to be worrisome, patients benefit from reassurance and education.
        </p>
        <p class="headingAnchor" id="H1772897698">
         <span class="h1">
          TREATABLE CAUSES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain causes of tinnitus can be addressed directly.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Vascular abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with vascular tinnitus may benefit from a variety of procedures. As examples, a bruit from an arteriovenous malformation, dural arteriovenous fistula, or dehiscent jugular bulb may be treated by ligation or embolization, and glomus tumors can be treated by angiographic embolization and surgical resection [
         <a href="#rid5">
          5-7
         </a>
         ].
        </p>
        <p>
         By contrast, reassurance is usually adequate for patients with venous hums or benign arterial variants causing pulsatile tinnitus. Rarely, surgical or angiographic ligation of the offending vessel is indicated for patients whose pulsatile tinnitus is so loud that it cannot be adequately treated with masking or other noninvasive treatment strategies and who experience significant impairment in their quality of life [
         <a href="#rid8">
          8,9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Drug toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tinnitus due to ototoxic effects on the hair cells of the cochlea may be reversible in patients after stopping ototoxic medications  (
         <a class="graphic graphic_table graphicRef68705" href="/z/d/graphic/68705.html" rel="external">
          table 1
         </a>
         ). Often tinnitus is the first sign that ototoxicity is occurring and can herald more severe injury to the inner ear. Discontinuing these medications can prevent progression to hearing loss and/or balance systems dysfunction in some patients even if tinnitus does not resolve. Cochlear rescue medications are under investigation in patients with chemotherapy-induced tinnitus [
         <a href="#rid10">
          10-13
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3591169154">
         <span class="h2">
          Hearing loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with bothersome tinnitus related to hearing loss lasting more than six months, the use of an appropriately fitted hearing aid may act to mask the tinnitus. As with other masking strategies, the tinnitus tends to return some time after the hearing aid is removed. In a trial comparing hearing aid use with a sound generator for tinnitus associated with hearing loss, both interventions had comparable benefits [
         <a href="#rid14">
          14,15
         </a>
         ]. Patients with conductive hearing loss due to outer ear or middle ear disease may benefit from surgery to correct the conductive defect which may then improve the severity of the tinnitus  (
         <a class="graphic graphic_table graphicRef53903" href="/z/d/graphic/53903.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid16">
          16,17
         </a>
         ]. These patients may also derive some benefit of a reduction in tinnitus severity by improving hearing levels with hearing aids if surgery is not an option.
        </p>
        <p>
         Cochlear implantation is a well-accepted therapy in adults and children with severe hearing impairment who are not benefiting from hearing aids. This electrical stimulation of the auditory pathway is also associated with a loss or reduction of tinnitus in 34 to 93 percent of patients receiving cochlear implants, although some individuals develop tinnitus postoperatively [
         <a href="#rid18">
          18-21
         </a>
         ]. In a case series of 21 patients with incapacitating tinnitus and unilateral deafness, cochlear implantation in the deaf ear resulted in reduction of tinnitus loudness and distress [
         <a href="#rid22">
          22
         </a>
         ]. However, a full evaluation for candidacy is required before a cochlear implant can be considered.
        </p>
        <p class="headingAnchor" id="H496929266">
         <span class="h2">
          Patulous Eustachian tube
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment of patulous Eustachian tube can help to improve or resolve tinnitus [
         <a href="#rid23">
          23
         </a>
         ]. A patulous Eustachian tube can be treated with a variety of agents, including application of mucosal irritants to the nasopharynx, which result in swelling or scarring of the Eustachian tube orifice, or various surgical techniques to close the nasopharyngeal orifice. This is discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/14608.html" rel="external">
          "Eustachian tube dysfunction", section on 'Patulous dysfunction'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4254983545">
         <span class="h2">
          Other causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Investigational therapies aimed at protecting the inner ear from noise trauma (noise induced damage) are being studied. To date there are only low levels of evidence for pharmacologic treatments for noise-induced tinnitus [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2622409658">
         <span class="h1">
          COEXISTING CONDITIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain conditions tend to coexist with tinnitus and should be treated concurrently.
        </p>
        <p class="headingAnchor" id="H3702253866">
         <span class="h2">
          Depression
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with depression require appropriate treatment. In a randomized trial, treatment with
         <a class="drug drug_general" data-topicid="9711" href="/z/d/drug information/9711.html" rel="external">
          nortriptyline
         </a>
         100 mg, compared with placebo, resulted in overall benefit for patients with disabling tinnitus (67 versus 40 percent), although tinnitus severity was not significantly improved [
         <a href="#rid25">
          25
         </a>
         ]. A meta-analysis of six randomized trials of antidepressants for treatment of tinnitus (four evaluating tricyclic antidepressants, one using
         <a class="drug drug_general" data-topicid="9743" href="/z/d/drug information/9743.html" rel="external">
          paroxetine
         </a>
         initiated at 10 mg daily, one studying
         <a class="drug drug_general" data-topicid="10013" href="/z/d/drug information/10013.html" rel="external">
          trazodone
         </a>
         ) found no conclusive evidence for the effectiveness of antidepressants in this condition [
         <a href="#rid26">
          26
         </a>
         ]. There was a suggestion of tinnitus improvement in a patient subgroup that received higher doses of paroxetine (50 mg) in one study [
         <a href="#rid27">
          27
         </a>
         ], but this requires further evaluation.
        </p>
        <p class="headingAnchor" id="H1230959436">
         <span class="h2">
          Insomnia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with tinnitus who have insomnia should be treated for their sleep disorder with the goal of reducing the extent to which the tinnitus affects their quality of life [
         <a href="#rid28">
          28
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/97867.html" rel="external">
          "Overview of the treatment of insomnia in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          BEHAVIORAL THERAPIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients in whom a treatable cause cannot be found, or for those who continue to have bothersome symptoms after available treatments, behavioral interventions may be useful. There has been reported success with:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tinnitus retraining therapy (TRT)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cognitive behavioral therapy (CBT)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Biofeedback and stress reduction programs
        </p>
        <p>
        </p>
        <p>
         Multidisciplinary programs at tinnitus centers are available to assist patients with disabling tinnitus. A randomized trial, performed in an audiologic referral center, compared a multidisciplinary stepped therapy approach (incorporating TRT and CBT and involving clinical psychologists, movement therapists, physical therapists, speech therapists, social workers, and audiologists) to usual care for 492 adult patients with tinnitus [
         <a href="#rid29">
          29
         </a>
         ]. At 12 months, patients assigned to the stepped therapy had significant improvement in scores reflecting health-related quality of life, tinnitus impairment, and tinnitus severity.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Tinnitus retraining therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         TRT is based upon bypassing or overriding abnormal auditory cortex neural connections. These therapies are performed at specialized tinnitus centers and in some audiologic practices; techniques vary among practitioners and each center has its own specific rates of success.
        </p>
        <p>
         TRT is based on the principle that all levels of the auditory pathways and several nonauditory systems play essential roles in tinnitus; TRT enhances the role of nonauditory systems in determining the level of tinnitus annoyance [
         <a href="#rid30">
          30
         </a>
         ]. TRT involves inducing and facilitating habituation to the tinnitus signal. The goal is to reach a stage in which patients are unaware of their tinnitus unless they specifically and consciously focus on it. Furthermore, even when perceived, tinnitus does not evoke annoyance. Habituation is achieved by directive counseling combined with low-level, broad-band noise generated by wearable generators, and environmental sounds, according to a specific protocol.
        </p>
        <p>
         High-quality data are limited [
         <a href="#rid31">
          31
         </a>
         ]. Significant improvement has been reported in case series and wait-list controlled studies, with as many as 80 percent of patients with high-pitched tinnitus experiencing improvement when using TRT with combined counseling and noise generators [
         <a href="#rid30">
          30,32-34
         </a>
         ]. The long-term impact may be less reliable [
         <a href="#rid35">
          35
         </a>
         ]. TRT can take one to two years before the patient no longer needs the external device.
        </p>
        <p>
         In a trial among 123 participants with tinnitus, TRT treatments every three months for 18 months were more effective at 12 months than tinnitus masking in improving symptoms as measured by self-administered tinnitus questionnaires [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Cognitive behavioral therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         CBT is an intervention directed at teaching patients to alter their psychological response to their tinnitus by identifying and reinforcing coping strategies, distraction skills, and relaxation techniques [
         <a href="#rid37">
          37
         </a>
         ]. Patients must be motivated, as they are required to keep diaries and perform homework as part of CBT.
        </p>
        <p>
         In a meta-analysis of 10 trials comparing different forms of CBT delivery (including group therapy and internet therapy) to controls, CBT improved tinnitus symptoms in nine trials [
         <a href="#rid2">
          2
         </a>
         ]. Internet-delivered CBT and self-help books may be useful in patients who cannot access a formal CBT program [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1172995773">
         <span class="h2">
          Biofeedback and stress reduction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Biofeedback is a relaxation technique that teaches people to control certain autonomic body functions. It was first described as a stand-alone therapy for tinnitus in the 1980s and continues to be used as part of a battery of therapy options at many tinnitus centers. The goal is to help people manage tinnitus-related distress by changing the patient's reaction to it. High quality data are limited, although many people notice a reduction in tinnitus when they are able to modify their reaction to it [
         <a href="#rid39">
          39,40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H504724126">
         <span class="h1">
          LIMITED ROLE FOR MEDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Medications are not a mainstay of tinnitus treatment. Systematic reviews of antidepressant therapies and anticonvulsants for tinnitus have not found evidence of efficacy [
         <a href="#rid26">
          26,41
         </a>
         ]. The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) guidelines state that clinicians should not routinely recommend antidepressants, anticonvulsants, anxiolytics, or intratympanic medications for treatment of treating persistent, bothersome tinnitus [
         <a href="#rid42">
          42
         </a>
         ]. Further, they also state that clinicians should not recommend ginkgo biloba, melatonin, zinc, or other dietary supplements for this purpose [
         <a href="#rid42">
          42
         </a>
         ].
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          Lidocaine
         </a>
         should not be used in the treatment of tinnitus [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Some medication therapies may have value:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Benzodiazepines (eg,
         <a class="drug drug_general" data-topicid="8453" href="/z/d/drug information/8453.html" rel="external">
          alprazolam
         </a>
         ) have been found in small trials to be effective in the treatment of tinnitus [
         <a href="#rid43">
          43,44
         </a>
         ] and are thought to act on the anxiety often associated with tinnitus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intratympanic medications, such as
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         , have been used with some success in patients with tinnitus, particularly in those with cochlear disease (eg, sudden hearing loss, autoimmune inner ear disease, Meniere disease) [
         <a href="#rid45">
          45,46
         </a>
         ]. In a small randomized trial of patients with idiopathic tinnitus of less than three months' duration, those who were assigned to combination intratympanic dexamethasone and oral
         <a class="drug drug_general" data-topicid="8453" href="/z/d/drug information/8453.html" rel="external">
          alprazolam
         </a>
         reported greater improvement in tinnitus symptoms, compared with oral alprazolam alone [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10015034">
         <span class="h1">
          MASKING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Masking is a general term for using one sound to block the perception of another sound. Masking is used for patients with hearing loss and tinnitus. (See
         <a class="local">
          'Hearing loss'
         </a>
         above.)
        </p>
        <p>
         Sound therapy uses maskers that are tuned by the audiologist to what is most effective for a specific patient. Masking devices resemble hearing aids and are designed to produce low-level sounds that reduce the perception of tinnitus [
         <a href="#rid48">
          48
         </a>
         ]. Some patients report decrease in tinnitus with use of such devices, although there is no conclusive evidence from randomized trials to clarify the evidence of effectiveness. One systematic review of eight trials found no evidence to support the superiority of sound therapy for tinnitus over placebo or education [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         Masking can also produce the phenomenon of residual inhibition, where the reduction or elimination of tinnitus perception continues for a short time after the masker is removed. One therapy under evaluation, phase-shift treatment, aims to enhance residual inhibition that results from masking. Similar to the concept used in sound cancellation headphones, phase-shift therapy uses a sound wave that is phase-shifted 180 degrees from the patient's endogenous sound wave. Residual inhibition lasting one hour to seven days was reported in 42 percent of patients during active phase-shift treatment for two weeks, and in no patients during nontreatment control weeks, in a crossover study (n = 61) [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         Potential adverse effects of masking therapy include worsening of tinnitus, associated discomfort, or worsening hyperacusis [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
         Masking may also be accomplished using or enhancing ambient background noise. Use of background music, sound machines, radios on low volume, fans, and pillow speakers have been helpful to patients with tinnitus that is especially bothersome in quiet environments.
        </p>
        <p class="headingAnchor" id="H2233724637">
         <span class="h1">
          INEFFECTIVE TREATEMENTS
         </span>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Electrical stimulation in patients without hearing loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Electrical stimulation of the cochlea by directly placing electrodes on the bony cochlea or in the round window niche have resulted in tinnitus improvement in patients with hearing loss. Transcutaneous electrical stimulation is the only available electrical option that is not associated with a risk of causing hearing loss [
         <a href="#rid52">
          52
         </a>
         ]. Electrical stimulation may be provided either through a single electrode or via multiple placed acupuncture needles over the mastoids or around the auricle.
        </p>
        <p>
         In patients without hearing loss, however, electrical stimulation external to the middle or inner ear has not been demonstrated to be more effective for tinnitus suppression than placebo treatment; responses were approximately 38 to 43 percent for both groups [
         <a href="#rid53">
          53,54
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Acupuncture
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acupuncture, alone or in conjunction with electrical stimulation, has not been found to be more effective than placebo [
         <a href="#rid55">
          55-57
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Repetitive transcranial magnetic stimulation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Repetitive transcranial magnetic stimulation (rTMS) has been investigated in patients with different medical conditions (eg, movement disorders, seizures, and depression) and has shown modest effectiveness. However, the American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) guidelines state that clinicians should not recommend rTMS for the routine treatment of patients with persistent, bothersome tinnitus [
         <a href="#rid42">
          42
         </a>
         ]. In a systematic review that included five small randomized trials of patients with tinnitus (n = 233), there were limited data showing improvement in severity or disability of tinnitus with rTMS therapy [
         <a href="#rid58">
          58
         </a>
         ]. A subsequent randomized trial in 64 participants with chronic tinnitus found that, compared with placebo, participants who received treatment with 10 consecutive days of rTMS were more likely to have improvement in tinnitus functional index (56 versus 22 percent) [
         <a href="#rid59">
          59
         </a>
         ]. Improvements were sustained during the 26-week follow-up period. Although rTMS appears to be safe in short-term treatment, safety with long-term treatment is not known. Larger trials are needed to determine the conditions and parameters under which rTMS may be effective.
        </p>
        <p class="headingAnchor" id="H579877130">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/126560.html" rel="external">
          "Society guideline links: Hearing loss and hearing disorders in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15484.html" rel="external">
          "Patient education: Tinnitus (ringing in the ears) (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/2731.html" rel="external">
          "Patient education: Tinnitus (ringing in the ears) (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatable causes
         </strong>
         – Treatment for tinnitus is be aimed at the underlying abnormality, when identified. (See
         <a class="local">
          'Treatable causes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sensorineural hearing loss – Cochlear implants for patients with severe sensorineural hearing loss may improve tinnitus. (See
         <a class="local">
          'Hearing loss'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vascular abnormalities – Patients with vascular tinnitus may benefit from a variety of procedures. (See
         <a class="local">
          'Vascular abnormalities'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Drug toxicity – Discontinuing of offending medications can reverse tinnitus and may prevent progression to hearing loss and/or balance systems dysfunction. (See
         <a class="local">
          'Drug toxicity'
         </a>
         above.)  (
         <a class="graphic graphic_table graphicRef68705" href="/z/d/graphic/68705.html" rel="external">
          table 1
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patulous Eustachian tube – Treatment of this condition can reduce or resolve tinnitus. (See
         <a class="local">
          'Patulous Eustachian tube'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Exacerbating conditions
         </strong>
         – We encourage treatment of underlying depression and insomnia, as these conditions may exacerbate symptoms of tinnitus. (See
         <a class="local">
          'Coexisting conditions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Behavioral therapies
         </strong>
         – For patients with no obvious treatable cause who are significantly impacted by their tinnitus symptoms, we suggest either tinnitus retraining therapy (TRT), or cognitive behavioral therapy (CBT) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). A trial of biofeedback may also be helpful as an adjunct to TRT or CBT. (See
         <a class="local">
          'Behavioral therapies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Limited role for medications
         </strong>
         – Medications for tinnitus have limited effectiveness. (See
         <a class="local">
          'Limited role for medications'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Ahmad N, Seidman M. Tinnitus in the older adult: epidemiology, pathophysiology and treatment options. Drugs Aging 2004; 21:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoare DJ, Kowalkowski VL, Kang S, Hall DA. Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Laryngoscope 2011; 121:1555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baguley D, McFerran D, Hall D. Tinnitus. Lancet 2013; 382:1600.
          </a>
         </li>
         <li class="breakAll">
          Agency for Healthcare Research and Quality. Evaluation and treatment of tinnitus: Comparative effectiveness. 2013. Available at: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&amp;productID=1649 (Accessed on October 08, 2013).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sismanis A. Pulsatile tinnitus: contemporary assessment and management. Curr Opin Otolaryngol Head Neck Surg 2011; 19:348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guss ZD, Batra S, Limb CJ, et al. Radiosurgery of glomus jugulare tumors: a meta-analysis. Int J Radiat Oncol Biol Phys 2011; 81:e497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanna M, Fois P, Pasanisi E, et al. Middle ear and mastoid glomus tumors (glomus tympanicum): an algorithm for the surgical management. Auris Nasus Larynx 2010; 37:661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hardison JE, Smith RB 3rd, Crawley IS, Battey LL. Self-heard venous hums. JAMA 1981; 245:1146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rothstein J, Hilger PA, Boies LR Jr. Venous hum as a cause of reversible factitious sensorineural hearing loss. Ann Otol Rhinol Laryngol 1985; 94:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campbell KC, Meech RP, Rybak LP, Hughes LF. The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. J Am Acad Audiol 2003; 14:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pirvola U, Xing-Qun L, Virkkala J, et al. Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation. J Neurosci 2000; 20:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez KA, Allen P, Campbell M, et al. Atorvastatin is associated with reduced cisplatin-induced hearing loss. J Clin Invest 2021; 131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Viglietta V, Shi F, Hu QY, et al. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. Invest New Drugs 2020; 38:1463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoare DJ, Edmondson-Jones M, Sereda M, et al. Amplification with hearing aids for patients with tinnitus and co-existing hearing loss. Cochrane Database Syst Rev 2014; :CD010151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parazzini M, Del Bo L, Jastreboff M, et al. Open ear hearing aids in tinnitus therapy: An efficacy comparison with sound generators. Int J Audiol 2011; 50:548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bast F, Mazurek B, Schrom T. Effect of stapedotomy on pre-operative tinnitus and its psychosomatic burden. Auris Nasus Larynx 2013; 40:530.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HC, Jang CH, Kim YY, et al. Role of preoperative air-bone gap in tinnitus outcome after tympanoplasty for chronic otitis media with tinnitus. Braz J Otorhinolaryngol 2018; 84:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aschendorff A, Pabst G, Klenzner T, Laszig R. Tinnitus in Cochlear Implant Users: The Freiburg Experience. Int Tinnitus J 1998; 4:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ito J. Tinnitus suppression in cochlear implant patients. Otolaryngol Head Neck Surg 1997; 117:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyamoto RT, Bichey BG. Cochlear implantation for tinnitus suppression. Otolaryngol Clin North Am 2003; 36:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quaranta N, Wagstaff S, Baguley DM. Tinnitus and cochlear implantation. Int J Audiol 2004; 43:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van de Heyning P, Vermeire K, Diebl M, et al. Incapacitating unilateral tinnitus in single-sided deafness treated by cochlear implantation. Ann Otol Rhinol Laryngol 2008; 117:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caffier PP, Sedlmaier B, Haupt H, et al. Impact of laser eustachian tuboplasty on middle ear ventilation, hearing, and tinnitus in chronic tube dysfunction. Ear Hear 2011; 32:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Natarajan N, Batts S, Stankovic KM. Noise-Induced Hearing Loss. J Clin Med 2023; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dobie RA, Sakai CS, Sullivan MD, et al. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit. Am J Otol 1993; 14:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baldo P, Doree C, Molin P, et al. Antidepressants for patients with tinnitus. Cochrane Database Syst Rev 2012; :CD003853.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson SK, Viirre ES, Bailey KA, et al. Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects. Psychosom Med 2005; 67:981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Folmer RL, Griest SE. Tinnitus and insomnia. Am J Otolaryngol 2000; 21:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cima RF, Maes IH, Joore MA, et al. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet 2012; 379:1951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jastreboff PJ, Gray WC, Gold SL. Neurophysiological approach to tinnitus patients. Am J Otol 1996; 17:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phillips JS, McFerran D. Tinnitus Retraining Therapy (TRT) for tinnitus. Cochrane Database Syst Rev 2010; :CD007330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herraiz C, Hernandez FJ, Plaza G, de los Santos G. Long-term clinical trial of tinnitus retraining therapy. Otolaryngol Head Neck Surg 2005; 133:774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jastreboff PJ, Jastreboff MM. Tinnitus retraining therapy for patients with tinnitus and decreased sound tolerance. Otolaryngol Clin North Am 2003; 36:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berry JA, Gold SL, Frederick EA, et al. Patient-based outcomes in patients with primary tinnitus undergoing tinnitus retraining therapy. Arch Otolaryngol Head Neck Surg 2002; 128:1153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dobie RA. A review of randomized clinical trials in tinnitus. Laryngoscope 1999; 109:1202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry JA, Schechter MA, Zaugg TL, et al. Clinical trial to compare tinnitus masking and tinnitus retraining therapy. Acta Otolaryngol Suppl 2006; :64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beukes EW, Andersson G, Allen PM, et al. Effectiveness of Guided Internet-Based Cognitive Behavioral Therapy vs Face-to-Face Clinical Care for Treatment of Tinnitus: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 2018; 144:1126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaldo V, Cars S, Rahnert M, et al. Use of a self-help book with weekly therapist contact to reduce tinnitus distress: a randomized controlled trial. J Psychosom Res 2007; 63:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersson G, Lyttkens L. A meta-analytic review of psychological treatments for tinnitus. Br J Audiol 1999; 33:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varela Barrenechea F. Efficacy of neurofeedback as a treatment for people with subjective tinnitus in reducing the symptom and related consequences: a systematic review from 2010 to 2020. Acta Otorrinolaringol Esp (Engl Ed) 2023; 74:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoekstra CE, Rynja SP, van Zanten GA, Rovers MM. Anticonvulsants for tinnitus. Cochrane Database Syst Rev 2011; :CD007960.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngol Head Neck Surg 2014; 151:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jalali MM, Kousha A, Naghavi SE, et al. The effects of alprazolam on tinnitus: a cross-over randomized clinical trial. Med Sci Monit 2009; 15:PI55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 1993; 119:842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slattery WH, Fisher LM, Iqbal Z, et al. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 2005; 133:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, et al. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005; 133:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shim HJ, Song SJ, Choi AY, et al. Comparison of various treatment modalities for acute tinnitus. Laryngoscope 2011; 121:2619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vernon JA, Meikle MB. Masking devices and alprazolam treatment for tinnitus. Otolaryngol Clin North Am 2003; 36:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sereda M, Xia J, El Refaie A, et al. Sound therapy (using amplification devices and/or sound generators) for tinnitus. Cochrane Database Syst Rev 2018; 12:CD013094.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lipman RI, Lipman SP. Phase-shift treatment for predominant tone tinnitus. Otolaryngol Head Neck Surg 2007; 136:763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Attarha M, Bigelow J, Merzenich MM. Unintended Consequences of White Noise Therapy for Tinnitus-Otolaryngology's Cobra Effect: A Review. JAMA Otolaryngol Head Neck Surg 2018; 144:938.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Konopka W, Zalewski P, Olszewski J, et al. Tinnitus suppression by electrical promontory stimulation (EPS) in patients with sensorineural hearing loss. Auris Nasus Larynx 2001; 28:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steenerson RL, Cronin GW. Treatment of tinnitus with electrical stimulation. Otolaryngol Head Neck Surg 1999; 121:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapkin O, Satar B, Yetiser S. Transcutaneous electrical stimulation of subjective tinnitus. A placebo-controlled, randomized and comparative analysis. ORL J Otorhinolaryngol Relat Spec 2008; 70:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Axelsson A, Andersson S, Gu LD. Acupuncture in the management of tinnitus: a placebo-controlled study. Audiology 1994; 33:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park J, White AR, Ernst E. Efficacy of acupuncture as a treatment for tinnitus: a systematic review. Arch Otolaryngol Head Neck Surg 2000; 126:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang K, Liang S, Chen L, Grellet A. Acupuncture for tinnitus: a systematic review and meta-analysis of randomized controlled trials. Acupunct Med 2021; 39:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meng Z, Liu S, Zheng Y, Phillips JS. Repetitive transcranial magnetic stimulation for tinnitus. Cochrane Database Syst Rev 2011; :CD007946.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Folmer RL, Theodoroff SM, Casiana L, et al. Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 2015; 141:716.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6856 Version 44.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15040757" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Tinnitus in the older adult: epidemiology, pathophysiology and treatment options.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21671234" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Systematic review and meta-analyses of randomized controlled trials examining tinnitus management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23827090" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23827090" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22552697" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Pulsatile tinnitus: contemporary assessment and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21703782" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Radiosurgery of glomus jugulare tumors: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20400250" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Middle ear and mastoid glomus tumors (glomus tympanicum): an algorithm for the surgical management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7463641" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Self-heard venous hums.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4014948" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Venous hum as a cause of reversible factitious sensorineural hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12859139" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10627579" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33393488" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Atorvastatin is associated with reduced cisplatin-induced hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32157599" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24482186" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Amplification with hearing aids for patients with tinnitus and co-existing hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21595527" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Open ear hearing aids in tinnitus therapy: An efficacy comparison with sound generators.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23706306" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Effect of stapedotomy on pre-operative tinnitus and its psychosomatic burden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28262542" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Role of preoperative air-bone gap in tinnitus outcome after tympanoplasty for chronic otitis media with tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10753408" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Tinnitus in Cochlear Implant Users: The Freiburg Experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9419102" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Tinnitus suppression in cochlear implant patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12856302" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Cochlear implantation for tinnitus suppression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15357407" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Tinnitus and cochlear implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18834065" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Incapacitating unilateral tinnitus in single-sided deafness treated by cochlear implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20585250" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Impact of laser eustachian tuboplasty on middle ear ventilation, hearing, and tinnitus in chronic tube dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36983347" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Noise-Induced Hearing Loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8424470" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22972065" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Antidepressants for patients with tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16314604" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11032291" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Tinnitus and insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22633033" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8723954" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Neurophysiological approach to tinnitus patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20238353" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Tinnitus Retraining Therapy (TRT) for tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16274808" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Long-term clinical trial of tinnitus retraining therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12856300" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Tinnitus retraining therapy for patients with tinnitus and decreased sound tolerance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12365886" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Patient-based outcomes in patients with primary tinnitus undergoing tinnitus retraining therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10443820" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : A review of randomized clinical trials in tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17114146" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Clinical trial to compare tinnitus masking and tinnitus retraining therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30286238" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Effectiveness of Guided Internet-Based Cognitive Behavioral Therapy vs Face-to-Face Clinical Care for Treatment of Tinnitus: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17662757" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Use of a self-help book with weekly therapist contact to reduce tinnitus distress: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10509855" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : A meta-analytic review of psychological treatments for tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36257576" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Efficacy of neurofeedback as a treatment for people with subjective tinnitus in reducing the symptom and related consequences: a systematic review from 2010 to 2020.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21735419" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Anticonvulsants for tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25274374" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Clinical practice guideline: tinnitus executive summary.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19865063" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : The effects of alprazolam on tinnitus: a cross-over randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8343245" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Use of alprazolam for relief of tinnitus. A double-blind study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16087024" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Intratympanic steroid injection for treatment of idiopathic sudden hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16087029" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22109762" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Comparison of various treatment modalities for acute tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12856299" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Masking devices and alprazolam treatment for tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30589445" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Sound therapy (using amplification devices and/or sound generators) for tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17478212" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Phase-shift treatment for predominant tone tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30178067" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Unintended Consequences of White Noise Therapy for Tinnitus-Otolaryngology's Cobra Effect: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11137361" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Tinnitus suppression by electrical promontory stimulation (EPS) in patients with sensorineural hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10547461" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Treatment of tinnitus with electrical stimulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18401195" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Transcutaneous electrical stimulation of subjective tinnitus. A placebo-controlled, randomized and comparative analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7741667" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Acupuncture in the management of tinnitus: a placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10772302" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Efficacy of acupuncture as a treatment for tinnitus: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32772848" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Acupuncture for tinnitus: a systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21975776" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Repetitive transcranial magnetic stimulation for tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26181507" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
